Program

  • Sessions
  • By day
  • Table
  • Sponsored
  • Topics

Opening Lecture

  • (OL01) Menopause: life style care and HRT for quality of life and health protection

    • Andrea Genazzani Menopause: life style care and HRT for quality of life and health protection

Key Lecture

  • (KL01) The obese pregnancy patient – an overview and management of labour

    • Dan Farine The obese pregnancy patient – an overview and management of labour
  • (KL02) Screening for gynecological malignancies

    • Joseph Schenker Screening for gynecological malignancies
  • (KL03) Hormonophobia – a threat to women health

    • Johannes Bitzer Hormonophobia – a threat to women health
  • (KL04) Surgical theraphy of urinary incontinence and prolapse

    • Heinz Koelbl Surgical theraphy of urinary incontinence and prolapse
  • (KL05) Estetrol, the first NEST with unique activity profile: new opportunities in Women’s Healthcare

    • J Michel Foidart ESTETROL , the first NEST with unique activity profile : new opportunities in Women’s healthcare
  • (KL06) Targeted therapies in gynecological oncology

    • Christian Singer Targeted therapies in gynecological oncology
  • Medicalization of pregnancy – Where are we heading ?

    • Yves Ville Medicalization of pregnancy – Where are we heading ?

Symposium

  • (SYMP01) Fertility preservation in cancer patients

    • Claus Y. Andersen Outlook for ovarian tissue freezing in a gynaecological context
    • Ana Teresa Almeida Santos Bridging the gap between oncologists and reproductive endocrinologists
    • Marie-Madeleine Dolmans From ovarian tissue reimplantation to the artificial ovary
    • Chiara Benedetto Mothers beyond cancer: a model to be shared
  • (SYMP02) Deferred embryo transfer

    • Peter Humaidan Indications
    • Carlos Dosouto Freeze all for all
    • Pedro N. Barri Uterine preparation for delayed embryo transfer
  • (SYMP03) Why women waits so long and how to face ?

    • Ronit Kochman Fertility alert – a wake-up call
    • Joelle Belaisch Allart Why do they wait ?
    • Antonio Pellicer Is preimplantation genetic testing for aneuploidies (PGT-A) the solution ?
  • (SYMP04) Early reproductive aging: the role of genetic and epigenetic factors

    • Felix Day The role of GWAS
    • Sven Skouby Translational medicine in reproductive aging
    • Michael Feichtinger Genetic variants in women with premature ovarian failure and poor ovarian response – a step towards preventive medicine ?
  • (SYMP05) OOCYTE quality in PCO and Endometriosis : is there a problem ?

    • Basil Tarlatzis Polycystic ovary
    • Bart Fauser PCOS, infertility care, pregnancy complications and children outcome
    • Paolo G. Artini Is the oocyte quality affected by endometriosis ?
    • Wilfried Feichtinger Is there an influence of endometriotic cysts on oocyte quality?
  • (SYMP06) Sexual and Reproductive health care – a forgotten part of obstetrics and gynecology

    • Johannes Bitzer The quality of SRH care across Europe and beyond
    • Gabriele Merki What can European societies contribute
    • Rossella Nappi How to prevent sexual dysfunction across reproductive life span
  • (SYMP07) Stem cells in reproductive medicine

    • Wolfgang Holzgreve Fetal stem cells in the maternal system. Clinical use and significance
    • Antonio Pellicer Ovarian rejuvenation: awakening follicles in POI patients
    • Johannes Huber Prevention of ageing ovaries. Menopause reversal as a viable option
  • (SYMP08) Preeclampsia screening and management

    • Stefan Verlohren The use of biomarkers to better predict and diagnose preeclampsia
    • Pavel Calda Preeclampsia screening and management two years after the ASPRE study
    • Harald Zeisler sFlt-1/PlGF-ratio: a milestone in the management of preeclampsia
    • Enrico Ferrazzi Maternal hemodinamcs in hipertensive disordes of pregnancy
  • (SYMP09) Transgender

    • Stefan Riedl Management of transgender adolescents
    • Juergen Schaff Modern concept of genital surgery in transgender treatment MtF and FtM
    • Michael van Trotsenburg Gender incongruence and fertility options
  • (SYMP10) Abnormally Invasive Placenta (AIP)

    • Braun Thorsten Epidemiology and pathophysiology of AIP
    • Frederic Chantraine US and MRI diagnostics
    • Olivier Morel Conservative management in AIP
    • Martin Langer Operative treatment in Abnormally Invasive Placenta
  • (SYMP11) Menopause in the context of healthy female aging

    • Ewald Boschitsch The role of MHT in fracture prevention
    • John Stevenson Cardiovascular prevention
    • Andrea Genazzani The brain: a menopause vulnerable organ
    • Rossella Nappi Sex and quality of life
  • (SYMP12) Menopause: individualized therapies for specific goals

    • Nick Panay Premature Ovarian Insufficiency
    • Alfred Mueck Main criteria for the choice of progestogens in HRT
    • Mark Brincat Menopause, ERT and connective tissue changes
    • Martin Birkhaeuser Tibolone – still an option?
  • (SYMP13) Supplements -facts & myths

    • Andrea Genazzani DHEA
    • Mark Brincat Vitamine D
    • Alessandro Genazzani Inositol
    • Christian Egarter Isoflavones
  • (SYMP14) Endocrine disruptors & Women Health

    • Charles Sultan The fetus , a target for endocrine disruptors
    • Andrzej Milewicz Bisphenol A and PCOS
    • Phillipe Bouchard Endocrine disruptors and cancer
  • (SYMP15) Metabolic disorders and Women Health

    • Alessandro Genazzani PCOS from adolescence to climacterium
    • Andrzej Milewicz Obesity and reproduction
    • Sven Skouby Menopause and metabolic disorders
  • (SYMP16) Endometriosis

    • Michelle Nisolle What kind of surgical procedures for pelvic pain ?
    • Nathalie Chabbert-Buffet What is the place of medical treatment
    • Leila Adamyan Limits of surgical and alternative therapies according to the age and needs of patients
    • Stefano Angioni What kind of approach for infertility ?
  • (SYMP17) Contracedption

    • Gabriele Merki Progestogen only contraception and depression
    • David Serfaty Current and future vaginal contraceptives
    • Christian Egarter LARC methods of contraception
    • Ali Kubba Contraception in the peri-menopause
  • (SYMP18) Management of hereditary breast and ovarian cancer

    • Judith Balmana Genetic background and prevalence of BRCA1 and 2 mutations
    • Christian Singer Prophylactic surgery and early cancer detection in mutation carriers
    • Kerstin Rhiem Synthetic lethality and PARP Inhibitors in breast and ovarian cancer
    • Nicoletta Biglia Tailored surgery for breast cancer in BRCA carriers
  • (SYMP19) Endocrine therapies in breast cancer – an update

    • Alfred Mueck Membrane-bound Hormone Receptors for prediction of breast cancer risk
    • Olivia Pagani Endocrine therapy in the premenopausal breast cancer
    • Christian Jackisch Overcoming resistance in endocrine-responsive advanced breast cancer
  • (SYMP20) Vaccine for cervical cancer prevention

    • Elmar Joura The nonavalent HPV vaccine: a scientific achievement and a protection for future generations
    • Jean Gondry Cervical dysplasia and low and high degree lesions in the vaccine’s era
    • Franco Borruto Shadows and lights of anti HPV vaccination
  • (SYMP21) Advances in laparoscopic and minimally invasive surgery

    • Stefano Angioni What are the real indications of single port laparoscopy today?
    • Horace Roman Endometriosis surgery and preservation of fertility, what surgeons should know
    • Angelos Daniilidis The role of tubal surgery in the era of ART
  • (SYMP22) Adolescent gynecology

    • Charles Sultan Endocrine and gynecological consequences of adolescent obesity
    • Michelle Nisolle Laparoscopic surgery for adolescent müllerian anomalies
    • George Creatsas How to reduce repeat abortions and repeat births in adolescents and young women?
    • Sophie Christine-Maitre What is known about pregnancies and Turner syndrome ?

Meet the Experts

  • (MTE01) Female reproductive organs microbiomas

    • Gary Ventolini Recent findings in vaginal microbioma and their clinical implications
    • Inmaculada Moreno Upper genital tract microbiome in reproduction, does it matter ?
  • (MTE02) Gynecological oncology: the ovarian cancer

    • Pier Luigi Benedetti Panici Ultra-radical surgery in ovarian cancer: lights and shadows
    • Alexander Reinthaller Update of surgical treatment in recurrent ovarian cancer
  • (MTE03) Urogynecology- the future of prolapse surgery: is mini-invasive surgery a game changer?

    • Tommaso Simoncini Why is robotic surgery attractive to perform sacrocolpopexy ?
    • Nikolaus Veit-Rubin Are there laparoscopic alternatives to sacrocolpopexy to treat advanced pelvic organ prolapse ?
  • (MTE04) Recent developments in ovarian stimulation for IVF

    • Basil Tarlatzis Ovarian stimulation for IVF in poor responders: what is the evidence
    • Georg Griesinger Luteal phase supplementation revisited